SEMINOMA
Clinical trials for SEMINOMA explained in plain language.
Never miss a new study
Get alerted when new SEMINOMA trials appear
Sign up with your email to follow new studies for SEMINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for incurable germ cell tumors? cabozantinib trial underway
Disease control OngoingThis study tests the drug cabozantinib in 50 adults with germ cell tumors (like testicular or ovarian cancer) that have not responded to standard chemotherapy. The goal is to see if the drug can shrink tumors or stop them from growing for at least 3 months. Participants will take…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: Jennifer King • Aim: Disease control
Last updated May 26, 2026 08:45 UTC
-
Could less be more? new trial aims to tame testicular cancer with milder treatment
Disease control OngoingThis study is testing a less intense combination of chemotherapy and radiation for people with stage IIA or IIB seminoma, a type of testicular cancer. The goal is to see if a milder treatment can still control the cancer while causing fewer side effects. About 135 participants wi…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated May 26, 2026 08:42 UTC
-
Immunotherapy duo takes on stubborn germ cell tumors
Disease control OngoingThis study tests two immunotherapy drugs, durvalumab and tremelimumab, in 30 adults with germ cell tumors that have come back or not responded to standard treatment. The goal is to see if the combination can shrink tumors and control the disease. Participants must have measurable…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
Testicular cancer trial aims to slash relapse risk with stronger chemo
Disease control OngoingThis study compares two chemotherapy approaches for men with stage I seminoma testicular cancer who have a higher risk of the cancer coming back. One group gets a single round of the standard drug carboplatin, while the other gets a stronger combination of three drugs (BEP). The …
Matched conditions: SEMINOMA
Phase: PHASE3 • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
Immunotherapy duo takes on rare tumors in nationwide trial
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in adults with over 50 types of rare cancers. The goal is to see if this drug combination can shrink tumors or stop them from growing. The trial is no longer enrolling new participants, but results will help guid…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
Blood marker may predict cancer return in testicular cancer patients
Knowledge-focused OngoingThis study is testing whether a blood marker called miRNA 371 can predict if germ cell tumors (a type of cancer) will return after treatment. Researchers will collect blood samples from 956 newly diagnosed patients and track their health over time. The goal is to see if this mark…
Matched conditions: SEMINOMA
Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated May 26, 2026 08:31 UTC